| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $383.5M | +21.9% |
| Cost of Revenue | $94.0M | +24.4% |
| Gross Profit | $289.5M | +21.0% |
| R&D Expense | $136.4M | -1.7% |
| SG&A Expense | $261.2M | +16.6% |
| Operating Income | -$122.4M | +4.9% |
| Pre-tax Income | -$145.6M | -8.9% |
| Income Tax | $771K | -17.5% |
| Net Income | -$146.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $169.6M | +81.5% |
| Accounts Receivable | $60.7M | +52.4% |
| Inventory | $57.7M | +37.4% |
| Current Assets | $449.8M | +13.7% |
| Total Assets | $974.8M | +3.7% |
| Current Liabilities | $75.1M | +1.5% |
| Total Liabilities | $207.8M | -56.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.3M | -6.2% |
| Capital Expenditures | $6.3M | -68.9% |
| Investing Cash Flow | $47.8M | +239.3% |
| Financing Cash Flow | $91.5M | +508.6% |
| Free Cash Flow | -$67.6M | +13.3% |
| -8.7% |
| EPS (Basic) | -$2.77 | +0.4% |
| EPS (Diluted) | -$2.77 | +0.4% |
| Stockholders' Equity |
| $766.9M |
| +66.1% |